
NEWS
MEDICAL CANNABIS NEWS, EVENTS & PRESS RELEASES

GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS ACROSS EUROPE, THE MIDDLE EAST AND AFRICA
BALTIMORE, MD – May 7, 2019 — Greater Cannabis Company (OTC: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with European-based Symtomax, a licensed group on medical cannabis cultivation, research and distribution with over 40 years of experience in the medical cannabis industry. Effective immediately, Symtomax will distribute on a white-label basis ...
Read More
Read More

EUROPE BLOOMS TO WORLD’S LARGEST LEGAL CANNABIS MARKET
In the next five years, Europe is set to become the world’s largest legal cannabis market. With a population of more than double that of the United States and Canada combined, the market is ripe, and the industry has grown more in the last year than the last six combined, according to a new report. ...
Read More
Read More
SYMTOMAX SUBMIT APPLICATION
Symtomax have submitted their application for licenses to cultivate, manufacture, distribute, import and export medical cannabis. Chairman of the Symtomax Group Paul Segal commented “this marks a very exciting time for Symtomax, having performed some very in depth feasibility studies; Portugal was the clear leader in our expansion plans. Not only does it offer an ideal climate for growing, it has a reputable agricultural and well developed transport infrastructure, together ...
Read More
Read More
Recent Posts
Symtomax Completes Test Crop 2021
June 2021 Symtomax Granted Approval to Cultivate, Sell and Export Medical Cannabis
May 2021 Completion of Greenhouses and Cultivation Site
February 2021 Construction & Cultivation Update
The science behind producing high quality medical cannabis.
Medical Cannabis Network visit Symtomax location in Beja.